- Home
- Publications
- Publication Search
- Publication Details
Title
MalDA, Accelerating Malaria Drug Discovery
Authors
Keywords
-
Journal
TRENDS IN PARASITOLOGY
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-02-26
DOI
10.1016/j.pt.2021.01.009
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- First‐in‐human clinical trial to assess the safety, tolerability and pharmacokinetics of P218, a novel candidate for malaria chemoprotection
- (2020) M. Farouk Chughlay et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Dual Plasmepsin-Targeting Antimalarial Agents Disrupt Multiple Stages of the Malaria Parasite Life Cycle
- (2020) Paola Favuzza et al. Cell Host & Microbe
- DNA-Encoded Library Screening as Core Platform Technology in Drug Discovery: Its Synthetic Method Development and Applications in DEL Synthesis
- (2020) Minsoo Song et al. JOURNAL OF MEDICINAL CHEMISTRY
- The molecular basis for sugar import in malaria parasites
- (2020) Abdul Aziz Qureshi et al. NATURE
- Probing the Open Global Health Chemical Diversity Library for Multistage-Active Starting Points for Next-Generation Antimalarials
- (2020) Matthew Abraham et al. ACS Infectious Diseases
- Safety, tolerability, pharmacokinetics, and antimalarial efficacy of a novel Plasmodium falciparum ATP4 inhibitor SJ733: a first-in-human and induced blood-stage malaria phase 1a/b trial
- (2020) Aditya H Gaur et al. LANCET INFECTIOUS DISEASES
- Pan-active imidazolopiperazine antimalarials target the Plasmodium falciparum intracellular secretory pathway
- (2020) Gregory M. LaMonte et al. Nature Communications
- Structural Basis for Blocking Sugar Uptake into the Malaria Parasite Plasmodium falciparum
- (2020) Xin Jiang et al. CELL
- Identifying purine nucleoside phosphorylase as the target of quinine using cellular thermal shift assay
- (2019) Jerzy M. Dziekan et al. Science Translational Medicine
- Lysyl-tRNA synthetase as a drug target in malaria and cryptosporidiosis
- (2019) Beatriz Baragaña et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Plasmodium Niemann-Pick type C1-related protein is a druggable target required for parasite membrane homeostasis
- (2019) Eva S Istvan et al. eLife
- Covalent Plasmodium falciparum-selective proteasome inhibitors exhibit a low propensity for generating resistance in vitro and synergize with multiple antimalarial agents
- (2019) Barbara H. Stokes et al. PLoS Pathogens
- Validation of the protein kinase PfCLK3 as a multistage cross-species malarial drug target
- (2019) Mahmood M. Alam et al. SCIENCE
- Antimalarial pantothenamide metabolites target acetyl–coenzyme A biosynthesis in Plasmodium falciparum
- (2019) Joost Schalkwijk et al. Science Translational Medicine
- The structure of the PA28–20S proteasome complex from Plasmodium falciparum and implications for proteostasis
- (2019) Stanley C. Xie et al. Nature Microbiology
- Remarkable similarity in Plasmodium falciparum and Plasmodium vivax geranylgeranyl diphosphate synthase dynamics and its implication for antimalarial drug design
- (2018) Aishwarya Venkatramani et al. Chemical Biology & Drug Design
- Genetic resistance to purine nucleoside phosphorylase inhibition inPlasmodium falciparum
- (2018) Rodrigo G. Ducati et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Uncovering the essential genes of the human malaria parasitePlasmodium falciparumby saturation mutagenesis
- (2018) Min Zhang et al. SCIENCE
- Mapping the malaria parasite druggable genome by using in vitro evolution and chemogenomics
- (2018) Annie N. Cowell et al. SCIENCE
- Using in Vitro Evolution and Whole Genome Analysis To Discover Next Generation Targets for Antimalarial Drug Discovery
- (2018) Madeline R. Luth et al. ACS Infectious Diseases
- A high throughput screen for next-generation leads targeting malaria parasite transmission
- (2018) Michael J. Delves et al. Nature Communications
- Target Validation and Identification of Novel Boronate Inhibitors of the Plasmodium falciparum Proteasome
- (2018) Stanley C. Xie et al. JOURNAL OF MEDICINAL CHEMISTRY
- Open-source discovery of chemical leads for next-generation chemoprotective antimalarials
- (2018) Yevgeniya Antonova-Koch et al. SCIENCE
- Development of a Potent Inhibitor of the Plasmodium Proteasome with Reduced Mammalian Toxicity
- (2017) Gregory M. LaMonte et al. JOURNAL OF MEDICINAL CHEMISTRY
- New developments in anti-malarial target candidate and product profiles
- (2017) Jeremy N. Burrows et al. MALARIA JOURNAL
- Plasmepsins IX and X are essential and druggable mediators of malaria parasite egress and invasion
- (2017) Armiyaw S. Nasamu et al. SCIENCE
- Antimalarial efficacy of MMV390048, an inhibitor of Plasmodium phosphatidylinositol 4-kinase
- (2017) Tanya Paquet et al. Science Translational Medicine
- Discovery of Antimalarial Azetidine-2-carbonitriles That Inhibit P. falciparum Dihydroorotate Dehydrogenase
- (2017) Micah Maetani et al. ACS Medicinal Chemistry Letters
- A potent antimalarial benzoxaborole targets a Plasmodium falciparum cleavage and polyadenylation specificity factor homologue
- (2017) Ebere Sonoiki et al. Nature Communications
- A potent series targeting the malarial cGMP-dependent protein kinase clears infection and blocks transmission
- (2017) David A. Baker et al. Nature Communications
- Metabolomic Profiling of the Malaria Box Reveals Antimalarial Target Pathways
- (2016) Erik L. Allman et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Dynamic Structure and Inhibition of a Malaria Drug Target: Geranylgeranyl Diphosphate Synthase
- (2016) Clarisse G. Ricci et al. BIOCHEMISTRY
- How to tackle antimalarial resistance?
- (2016) Didier Leroy EMBO Molecular Medicine
- Indels, structural variation, and recombination drive genomic diversity inPlasmodium falciparum
- (2016) Alistair Miles et al. GENOME RESEARCH
- DNA-Encoded Library Screening Identifies Benzo[b][1,4]oxazepin-4-ones as Highly Potent and Monoselective Receptor Interacting Protein 1 Kinase Inhibitors
- (2016) Philip A. Harris et al. JOURNAL OF MEDICINAL CHEMISTRY
- Antimalarial activity of artefenomel (OZ439), a novel synthetic antimalarial endoperoxide, in patients with Plasmodium falciparum and Plasmodium vivax malaria: an open-label phase 2 trial
- (2016) Aung Pyae Phyo et al. LANCET INFECTIOUS DISEASES
- Structure- and function-based design of Plasmodium-selective proteasome inhibitors
- (2016) Hao Li et al. NATURE
- Diversity-oriented synthesis yields novel multistage antimalarial inhibitors
- (2016) Nobutaka Kato et al. NATURE
- Dimerization of Arginyl-tRNA Synthetase by Free Heme Drives Its Inactivation in Plasmodium falciparum
- (2016) Vitul Jain et al. STRUCTURE
- Mutations in the Plasmodium falciparum Cyclic Amine Resistance Locus (PfCARL) Confer Multidrug Resistance
- (2016) Gregory LaMonte et al. mBio
- A broad analysis of resistance development in the malaria parasite
- (2016) Victoria C. Corey et al. Nature Communications
- Synthetic RNA–protein modules integrated with native translation mechanisms to control gene expression in malaria parasites
- (2016) Suresh M. Ganesan et al. Nature Communications
- Plasmodium falciparum Cyclic Amine Resistance Locus (PfCARL), a Resistance Mechanism for Two Distinct Compound Classes
- (2016) Pamela A. Magistrado et al. ACS Infectious Diseases
- A Triazolopyrimidine-Based Dihydroorotate Dehydrogenase Inhibitor with Improved Drug-like Properties for Treatment and Prevention of Malaria
- (2016) Margaret A. Phillips et al. ACS Infectious Diseases
- UDP-galactose and acetyl-CoA transporters as Plasmodium multidrug resistance genes
- (2016) Michelle Yi-Xiu Lim et al. Nature Microbiology
- Selective inhibition of apicoplast tryptophanyl-tRNA synthetase causes delayed death in Plasmodium falciparum
- (2016) Charisse Flerida A. Pasaje et al. Scientific Reports
- Efficacy of Synriam™, a new antimalarial combination of OZ277 and piperaquine, against different developmental stages of Schistosoma mansoni
- (2015) Shereen F. Mossallam et al. ACTA TROPICA
- Novel pantothenate derivatives for anti-malarial chemotherapy
- (2015) Helmi E Pett et al. MALARIA JOURNAL
- A novel multiple-stage antimalarial agent that inhibits protein synthesis
- (2015) Beatriz Baragaña et al. NATURE
- Cooperative development of antimicrobials: looking back to look ahead
- (2015) Carl Nathan NATURE REVIEWS MICROBIOLOGY
- Structural basis for plasmepsin V inhibition that blocks export of malaria proteins to human erythrocytes
- (2015) Anthony N Hodder et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- The cytoplasmic prolyl-tRNA synthetase of the malaria parasite is a dual-stage target of febrifugine and its analogs
- (2015) Jonathan D. Herman et al. Science Translational Medicine
- A long-duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malaria
- (2015) Margaret A. Phillips et al. Science Translational Medicine
- Structural basis for plasmepsin V inhibition that blocks export of malaria proteins to human erythrocytes
- (2015) Anthony N Hodder et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Mutations in the P-Type Cation-Transporter ATPase 4, PfATP4, Mediate Resistance to Both Aminopyrazole and Spiroindolone Antimalarials
- (2014) Erika L. Flannery et al. ACS Chemical Biology
- A First-in-Human Randomized, Double-Blind, Placebo-Controlled, Single- and Multiple-Ascending Oral Dose Study of Novel Imidazolopiperazine KAF156 To Assess Its Safety, Tolerability, and Pharmacokinetics in Healthy Adult Volunteers
- (2014) F. Joel Leong et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- KAF156 Is an Antimalarial Clinical Candidate with Potential for Use in Prophylaxis, Treatment, and Prevention of Disease Transmission
- (2014) Kelli L. Kuhen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Diversity-Oriented Synthesis Probe TargetsPlasmodium falciparumCytochrome b Ubiquinone Reduction Site and Synergizes With Oxidation Site Inhibitors
- (2014) Amanda K. Lukens et al. JOURNAL OF INFECTIOUS DISEASES
- Genome editing in the human malaria parasite Plasmodium falciparum using the CRISPR-Cas9 system
- (2014) Mehdi Ghorbal et al. NATURE BIOTECHNOLOGY
- Efficient CRISPR-Cas9–mediated genome editing in Plasmodium falciparum
- (2014) Jeffrey C Wagner et al. NATURE METHODS
- (+)-SJ733, a clinical candidate for malaria that acts through ATP4 to induce rapid host-mediated clearance ofPlasmodium
- (2014) María Belén Jiménez-Díaz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A barcode of organellar genome polymorphisms identifies the geographic origin of Plasmodium falciparum strains
- (2014) Mark D. Preston et al. Nature Communications
- Versatile control of Plasmodium falciparum gene expression with an inducible protein–RNA interaction
- (2014) Stephen J. Goldfless et al. Nature Communications
- Cloning and characterization of bifunctional enzyme farnesyl diphosphate/geranylgeranyl diphosphate synthase from Plasmodium falciparum
- (2013) Fabiana M Jordão et al. MALARIA JOURNAL
- Crystal structures of Plasmodium falciparum cytosolic tryptophanyl-tRNA synthetase and its potential as a target for structure-guided drug design
- (2013) Cho Yeow Koh et al. MOLECULAR AND BIOCHEMICAL PARASITOLOGY
- High-level semi-synthetic production of the potent antimalarial artemisinin
- (2013) C. J. Paddon et al. NATURE
- Targeting Plasmodium PI(4)K to eliminate malaria
- (2013) Case W. McNamara et al. NATURE
- Quinolone-3-Diarylethers: A New Class of Antimalarial Drug
- (2013) A. Nilsen et al. Science Translational Medicine
- Mitotic Evolution of Plasmodium falciparum Shows a Stable Core Genome but Recombination in Antigen Families
- (2013) Selina E. R. Bopp et al. PLoS Genetics
- Asexual Populations of the Human Malaria Parasite, Plasmodium falciparum, Use a Two-Step Genomic Strategy to Acquire Accurate, Beneficial DNA Amplifications
- (2013) Jennifer L. Guler et al. PLoS Pathogens
- Selective and Specific Inhibition of the Plasmodium falciparum Lysyl-tRNA Synthetase by the Fungal Secondary Metabolite Cladosporin
- (2012) Dominic Hoepfner et al. Cell Host & Microbe
- Characterization of Plasmodium Liver Stage Inhibition by Halofuginone
- (2012) Emily R. Derbyshire et al. ChemMedChem
- Halofuginone and other febrifugine derivatives inhibit prolyl-tRNA synthetase
- (2012) Tracy L Keller et al. Nature Chemical Biology
- Malarial dihydrofolate reductase as a paradigm for drug development against a resistance-compromised target
- (2012) Y. Yuthavong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Chemical Genomic Analysis of Decoquinate, aPlasmodium falciparumCytochromebInhibitor
- (2011) Tae-gyu Nam et al. ACS Chemical Biology
- Potent antimalarial 4-pyridones with improved physico-chemical properties
- (2011) José M. Bueno et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Identification and Validation of Tetracyclic Benzothiazepines as Plasmodium falciparum Cytochrome bc1 Inhibitors
- (2011) Carolyn K. Dong et al. CHEMISTRY & BIOLOGY
- Reverse Fosmidomycin Derivatives against the Antimalarial Drug Target IspC (Dxr)
- (2011) Christoph T. Behrendt et al. JOURNAL OF MEDICINAL CHEMISTRY
- Natural products as starting points for future anti-malarial therapies: going back to our roots?
- (2011) Timothy NC Wells MALARIA JOURNAL
- Validation of isoleucine utilization targets in Plasmodium falciparum
- (2011) E. S. Istvan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malaria
- (2011) S. A. Charman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Imaging of Plasmodium Liver Stages to Drive Next-Generation Antimalarial Drug Discovery
- (2011) S. Meister et al. SCIENCE
- Optimization of Potent Inhibitors of P. falciparum Dihydroorotate Dehydrogenase for the Treatment of Malaria
- (2011) Renato T. Skerlj et al. ACS Medicinal Chemistry Letters
- Malaria parasite tyrosyl-tRNA synthetase secretion triggers pro-inflammatory responses
- (2011) Tarun Kumar Bhatt et al. Nature Communications
- Novel Inhibitors ofPlasmodium falciparumDihydroorotate Dehydrogenase with Anti-malarial Activity in the Mouse Model
- (2010) Michael L. Booker et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Thousands of chemical starting points for antimalarial lead identification
- (2010) Francisco-Javier Gamo et al. NATURE
- Chemical genetics of Plasmodium falciparum
- (2010) W. Armand Guiguemde et al. NATURE
- Spiroindolones, a Potent Compound Class for the Treatment of Malaria
- (2010) M. Rottmann et al. SCIENCE
- The Structure−Activity Relationship of the Antimalarial Ozonide Arterolane (OZ277)
- (2009) Yuxiang Dong et al. JOURNAL OF MEDICINAL CHEMISTRY
- Design, synthesis and selection of DNA-encoded small-molecule libraries
- (2009) Matthew A Clark et al. Nature Chemical Biology
- Diversity of degradation signals in the ubiquitin–proteasome system
- (2008) Tommer Ravid et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- In silicoactivity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen
- (2008) David Plouffe et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started